APGE Collar Strategy
APGE (Apogee Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
APGE (Apogee Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $8.33B, a beta of 0.34 versus the broader market, a 52-week range of 35.39-134.88, average daily share volume of 2.1M, a public-listing history dating back to 2023, approximately 261 full-time employees. These structural characteristics shape how APGE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.34 indicates APGE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on APGE?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
APGE snapshot
As of August 14, 2026, spot at $134.56, ATM IV 4.10%, IV rank 0.68%, expected move 1.18%. The collar on APGE below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this collar structure on APGE specifically: IV regime affects collar pricing on both sides; compressed APGE IV at 4.10% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 1.18% (roughly $1.58 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated APGE expiries trade a higher absolute premium for lower per-day decay. Position sizing on APGE should anchor to the underlying notional of $134.56 per share and to the trader's directional view on APGE stock.
APGE collar setup
The APGE collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With APGE at $134.56 on that close, the first option leg uses a $140.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed APGE chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 APGE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $134.56 | long |
| Sell 1 | Call | $140.00 | $0.03 |
| Buy 1 | Put | $130.00 | $0.15 |
APGE collar risk and reward
- Net Premium / Debit
- -$13,468.00
- Max Profit (per contract)
- $532.00
- Max Loss (per contract)
- -$468.00
- Breakeven(s)
- $134.68
- Risk / Reward Ratio
- 1.137
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
APGE collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on APGE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$468.00 |
| $29.76 | -77.9% | -$468.00 |
| $59.51 | -55.8% | -$468.00 |
| $89.26 | -33.7% | -$468.00 |
| $119.01 | -11.6% | -$468.00 |
| $148.76 | +10.6% | +$532.00 |
| $178.52 | +32.7% | +$532.00 |
| $208.27 | +54.8% | +$532.00 |
| $238.02 | +76.9% | +$532.00 |
| $267.77 | +99.0% | +$532.00 |
When traders use collar on APGE
Collars on APGE hedge an existing long APGE stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
APGE thesis for this collar
The market-implied 1-standard-deviation range for APGE extends from approximately $132.98 on the downside to $136.14 on the upside. A APGE collar hedges an existing long APGE position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current APGE IV rank near 0.68% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on APGE at 4.10%. As a Healthcare name, APGE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to APGE-specific events.
APGE collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. APGE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move APGE alongside the broader basket even when APGE-specific fundamentals are unchanged. Always rebuild the position from current APGE chain quotes before placing a trade.
Frequently asked questions
- What is a collar on APGE?
- A collar on APGE is the collar strategy applied to APGE (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With APGE stock at $134.56 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed APGE chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are APGE collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the APGE collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 4.10%), the computed maximum profit is $532.00 per contract and the computed maximum loss is -$468.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a APGE collar?
- The breakeven for the APGE collar priced on this page is roughly $134.68 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The APGE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 1.18%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on APGE?
- Collars on APGE hedge an existing long APGE stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current APGE implied volatility affect this collar?
- APGE ATM IV is at 4.10% with IV rank near 0.68%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.